NI201400106A - Composiciones de acción prolongada - Google Patents

Composiciones de acción prolongada

Info

Publication number
NI201400106A
NI201400106A NI201400106A NI201400106A NI201400106A NI 201400106 A NI201400106 A NI 201400106A NI 201400106 A NI201400106 A NI 201400106A NI 201400106 A NI201400106 A NI 201400106A NI 201400106 A NI201400106 A NI 201400106A
Authority
NI
Nicaragua
Prior art keywords
long
term action
action compositions
compositions
composition
Prior art date
Application number
NI201400106A
Other languages
English (en)
Inventor
Al Alawi Fadil
Nanjan Karthigeyan
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49161532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201400106(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of NI201400106A publication Critical patent/NI201400106A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención hace referencia a una composición de acción prolongada para tratar un animal que requiere tratamiento y que incluye una cantidad terapéuticamente eficaz de un agente bioactivo, caracterizada porque la composición incluye un portador no acuoso y un sistema solvente que comprende aceite de ricino y al menos una amida ciclica.
NI201400106A 2012-03-13 2014-09-11 Composiciones de acción prolongada NI201400106A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ59875712 2012-03-13

Publications (1)

Publication Number Publication Date
NI201400106A true NI201400106A (es) 2015-01-14

Family

ID=49161532

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201400106A NI201400106A (es) 2012-03-13 2014-09-11 Composiciones de acción prolongada

Country Status (20)

Country Link
US (1) US9616044B2 (es)
EP (1) EP2825154A4 (es)
JP (1) JP6273252B2 (es)
KR (1) KR20140136005A (es)
CN (1) CN104168886A (es)
AU (1) AU2013201479C1 (es)
CA (1) CA2867079A1 (es)
CL (1) CL2014002401A1 (es)
CO (1) CO7071132A2 (es)
CR (1) CR20140423A (es)
DO (1) DOP2014000207A (es)
IL (1) IL234597A0 (es)
MX (1) MX354966B (es)
NI (1) NI201400106A (es)
PE (1) PE20142279A1 (es)
PH (1) PH12014502016B1 (es)
RU (1) RU2014141088A (es)
SV (1) SV2014004804A (es)
WO (1) WO2013137748A1 (es)
ZA (1) ZA201406753B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
DK0535734T3 (da) * 1991-09-30 1999-08-09 Merck & Co Inc Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
AU713580B2 (en) 1995-09-25 1999-12-02 Merial Ltd Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6998131B2 (en) * 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
GB9815801D0 (en) * 1998-07-21 1998-09-16 Merck & Co Inc Liquid polymeric compositions for controlled released bioactive substances
CN1130990C (zh) 1999-11-02 2003-12-17 王毅远 一种纯天然方便食品及其制造方法
US6340672B1 (en) 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
AU781682B2 (en) 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
CN1383821A (zh) 2001-03-16 2002-12-11 王玉万 一种含丙硫苯咪唑亚砜或其盐类的兽用注射剂
AU2002100152A4 (en) * 2002-02-28 2002-04-11 Jurox Pty Ltd Parasiticide composition
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
CN1490009A (zh) * 2002-10-17 2004-04-21 王玉万 含抗球虫药物的缓释注射剂
US20060257440A1 (en) * 2003-05-19 2006-11-16 Makoto Asai Insecticidal composition
NZ535644A (en) 2003-07-25 2007-05-31 Ashmont Holdings Ltd Anthelmintic formulations
CN1293921C (zh) 2003-08-18 2007-01-10 王玉万 含乙基纤维素和脂肪酸酯类的长效注射剂
TR200601608T1 (tr) 2003-10-17 2006-12-21 Akzo Nobel N.V Bir avermektin kombinasyonu içeren uzun süre etkili bileşimler.
AU2005100403B4 (en) * 2005-05-13 2005-09-01 Jurox Pty Ltd Parasiticide Composition
BRPI0800259A2 (pt) * 2008-02-27 2011-05-31 Noxon Do Brasil Quimica E Farmaceutica Ltda formulações veterinárias compreendendo lactonas macrocìclicas e minerais, seus usos na preparação de produtos veterinários e métodos de ganho de produtividade e tratamento e/ou profilaxia de doenças causadas por agentes biológicos nocivos à saúde animal
AU2009271299B2 (en) 2008-06-24 2014-09-11 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic formulations
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
EP2396006B1 (en) * 2009-02-16 2012-12-19 Pfizer Inc. High dosage doramectin formulation
CN101703776B (zh) * 2009-09-28 2012-07-11 洛阳惠中兽药有限公司 一种抗感染剂长效注射液的制备方法
BRPI1001224A2 (pt) 2010-04-07 2011-03-15 Clarion Biociencias Ltda processo de fabricação de formulação injetável a base de fluazuron associado a avermectinas para o controle e prevenção de endo e ectoparasitas em animais domésticos
CN103260620A (zh) * 2010-12-27 2013-08-21 英特维特国际股份有限公司 包含三缩四乙二醇的外用局部异噁唑啉制剂

Also Published As

Publication number Publication date
EP2825154A4 (en) 2015-11-11
KR20140136005A (ko) 2014-11-27
CO7071132A2 (es) 2014-09-30
EP2825154A1 (en) 2015-01-21
AU2013201479A1 (en) 2013-10-03
PH12014502016A1 (en) 2014-11-24
JP6273252B2 (ja) 2018-01-31
CR20140423A (es) 2014-10-20
CL2014002401A1 (es) 2015-04-17
PE20142279A1 (es) 2015-01-25
AU2013201479C1 (en) 2017-11-09
US20150038565A1 (en) 2015-02-05
MX2014010957A (es) 2014-10-13
CA2867079A1 (en) 2013-09-19
AU2013201479B2 (en) 2015-07-02
SV2014004804A (es) 2017-04-20
JP2015509978A (ja) 2015-04-02
WO2013137748A1 (en) 2013-09-19
DOP2014000207A (es) 2014-11-30
US9616044B2 (en) 2017-04-11
ZA201406753B (en) 2015-12-23
RU2014141088A (ru) 2016-05-10
CN104168886A (zh) 2014-11-26
PH12014502016B1 (en) 2014-11-24
IL234597A0 (en) 2014-11-30
MX354966B (es) 2018-03-27

Similar Documents

Publication Publication Date Title
BR112016003201A2 (pt) inibidores de grp94 seletivos e usos dos mesmos
NI201600051A (es) Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CL2014002087A1 (es) Composición veterinaria masticable que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal.
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
DOP2016000253A (es) Nuevos compuestos
CR20160308A (es) Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
CR20140367A (es) Inhibidores de iap
NZ710602A (en) Methods for reducing pyrogenicity in a seaweed extract
BR112015024860A2 (pt) vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
BR112016000338A8 (pt) composto enriquecido em deutério de fórmula estrutural i, composição farmacêutica, e usos de um composto
CO2018002428A2 (es) Amida seleccionada de ácido gamma-hidroxiburico y usos de la misma en el tratamiento de abuso de alcohol
NI201500007A (es) Formulación transdérmica que contiene inhibidores de cox
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
MX2015012455A (es) Metodo para el tratamiento de la enfermedad de higado graso.
NI201400106A (es) Composiciones de acción prolongada
CL2015001646A1 (es) Agentes herbicidas que contienen aclonifeno
AR094809A1 (es) Tratamiento de formas progresivas de esclerosis múltiple con laquinimod
AR091784A1 (es) Formaciones inyectables de antibiotico y sus metodos de aplicacion
IN2013MU01222A (es)
UA71827U (en) Composition of a dressing agent